Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine for Neonatal Rapid Sequence Intubation
NCT01595399Phase 4Unknown
- Sponsor
- University of Manitoba
- Start
- Apr 2012
- Primary completion
- Jun 2014
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of atropine in bradycardia and hypoxemia, sponsored by University of Manitoba. Primary endpoint: Heart rate less than 80 BPM and oxygen saturation less than 80%. Status: unknown.
02
Drugs
atropine
03
Conditions
bradycardiahypoxemia
Beyond the preview
Go deeper on NCT01595399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01595399.